Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
57
NMPA:57
Drug Approvals
Bisoprolol Fumarate Tablets
- Product Name
- 富马酸比索洛尔片
- Approval Number
- 国药准字H20253012
- Approval Date
- Jan 2, 2025
NMPA
Bisoprolol Fumarate Tablets
- Product Name
- 富马酸比索洛尔片
- Approval Number
- 国药准字H20253013
- Approval Date
- Jan 2, 2025
NMPA
Moxifloxacin Hydrochloride and Sodium Chloride Injection
- Product Name
- 盐酸莫西沙星氯化钠注射液
- Approval Number
- 国药准字H20249449
- Approval Date
- Nov 22, 2024
NMPA
Parecoxib Sodium for Injection
- Product Name
- 注射用帕瑞昔布钠
- Approval Number
- 国药准字H20233580
- Approval Date
- May 19, 2023
NMPA
Parecoxib Sodium for Injection
- Product Name
- 注射用帕瑞昔布钠
- Approval Number
- 国药准字H20233579
- Approval Date
- May 19, 2023
NMPA
Metformin Hydrochloride Sustained-release Tablets
- Product Name
- 盐酸二甲双胍缓释片
- Approval Number
- 国药准字H20233284
- Approval Date
- Mar 21, 2023
NMPA
Cefpirome Sulfate for Injection
- Product Name
- 注射用硫酸头孢匹罗
- Approval Number
- 国药准字H20064627
- Approval Date
- Nov 13, 2022
NMPA
Cefpirome Sulfate for Injection
- Product Name
- 注射用硫酸头孢匹罗
- Approval Number
- 国药准字H20064628
- Approval Date
- Nov 13, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found